Skip to main content
Erschienen in: Abdominal Radiology 5/2017

10.01.2017 | Pictorial Essay

Getting the GIST: a pictorial review of the various patterns of presentation of gastrointestinal stromal tumors on imaging

verfasst von: Dominic Scola, Lawrence Bahoura, Alexander Copelan, Ali Shirkhoda, Farnoosh Sokhandon

Erschienen in: Abdominal Radiology | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Gastrointestinal stromal tumors (GISTs), the most common mesenchymal tumors of the gastrointestinal tract, are a relatively recently described entity. Most exhibit a mutated tyrosine kinase receptor gene and in some capacity are treated by tyrosine kinase inhibitors. GISTs can occur across the age spectrum but are more common in patients older than 40 years. They exhibit a wide range of clinical presentations and imaging characteristics. All patterns of enhancement on contrast enhanced computed tomography (CECT) can be seen with GISTs, including hypoenhancing, isoenhancing, and hyperenhancing tumors. They can be large or small, endoluminal or exophytic. Clinical presentations include asymptomatic patients, nonspecific symptoms, obstruction, and bleeding. Bleeding can take the form of slow, intraluminal GI bleeding or massive intraperitoneal bleeding secondary to rupture and can be seen regardless of the enhancement pattern. Some can cavitate, ulcerate, rupture or cause fistulae. The radiologist’s knowledge of the variety of combinations of presentations can narrow the differential diagnosis and ultimately lead to faster diagnosis and treatment.
Literatur
1.
Zurück zum Zitat Koumarianou A, Economopoulou P, Katsaounis P, et al. (2015) Gastrointestinal stromal tumors (GIST): a prospective analysis and an update on biomarkers and current treatment concepts. Biomark Cancer 7(Suppl 1):1–7PubMedPubMedCentral Koumarianou A, Economopoulou P, Katsaounis P, et al. (2015) Gastrointestinal stromal tumors (GIST): a prospective analysis and an update on biomarkers and current treatment concepts. Biomark Cancer 7(Suppl 1):1–7PubMedPubMedCentral
3.
Zurück zum Zitat Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M (2003) Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics 23(2):283–304CrossRef Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M (2003) Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics 23(2):283–304CrossRef
4.
Zurück zum Zitat Ma GL, Murphy JD, Martinez ME, Sicklick JK (2015) Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based study. Cancer Epidemiol Biomark Prevent 24(1):298–302CrossRef Ma GL, Murphy JD, Martinez ME, Sicklick JK (2015) Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based study. Cancer Epidemiol Biomark Prevent 24(1):298–302CrossRef
5.
Zurück zum Zitat Tiruman SH, Jagannathan JP, Krajewski KM, et al. (2013) Imatinib and beyond in gastrointestinal stromal tumors: a radiologist’s perspective. Am J Roentgenol 201:801–810CrossRef Tiruman SH, Jagannathan JP, Krajewski KM, et al. (2013) Imatinib and beyond in gastrointestinal stromal tumors: a radiologist’s perspective. Am J Roentgenol 201:801–810CrossRef
6.
Zurück zum Zitat Sanders KM, Koh SD, Ward SM (2006) Interstitial cells of Cajal as pacemakers in the gastrointestinal tract. Annu Rev Physiol 68:307–343CrossRef Sanders KM, Koh SD, Ward SM (2006) Interstitial cells of Cajal as pacemakers in the gastrointestinal tract. Annu Rev Physiol 68:307–343CrossRef
7.
Zurück zum Zitat Foo WC, Liegl-Atzwanger B, Lazar AJ (2012) Pathology of gastrointestinal stromal tumors. Clin Med Insights Pathol 5:23–33CrossRef Foo WC, Liegl-Atzwanger B, Lazar AJ (2012) Pathology of gastrointestinal stromal tumors. Clin Med Insights Pathol 5:23–33CrossRef
8.
Zurück zum Zitat Gold JS, Gönen M, Gutiérrez A, et al. (1045) Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol 2009:10 Gold JS, Gönen M, Gutiérrez A, et al. (1045) Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol 2009:10
9.
Zurück zum Zitat DeMatteo RP, Lewis JJ, Leung D, et al. (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231(1):51–58CrossRef DeMatteo RP, Lewis JJ, Leung D, et al. (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231(1):51–58CrossRef
10.
Zurück zum Zitat Pierie JP, Choudry U, Muzikansky A, et al. (2001) The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 136(4):383–389CrossRef Pierie JP, Choudry U, Muzikansky A, et al. (2001) The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 136(4):383–389CrossRef
11.
Zurück zum Zitat Naguib SF, Zaghloul AS, El Marakby H (2008) Gastrointestinal stromal tumors (GIST) of the stomach: retrospective experience with surgical resection at the National Cancer Institute. J Egypt Natl Cancer Inst 20(1):80–89 Naguib SF, Zaghloul AS, El Marakby H (2008) Gastrointestinal stromal tumors (GIST) of the stomach: retrospective experience with surgical resection at the National Cancer Institute. J Egypt Natl Cancer Inst 20(1):80–89
12.
Zurück zum Zitat Canda AE, Ozsoy Y, Nalbant OA, Sagol O (2008) Gastrointestinal stromal tumor of the stomach with lymph node metastasis. World J Surg Oncol 6:97CrossRef Canda AE, Ozsoy Y, Nalbant OA, Sagol O (2008) Gastrointestinal stromal tumor of the stomach with lymph node metastasis. World J Surg Oncol 6:97CrossRef
13.
Zurück zum Zitat Watson GA, Kelly D, Melland-Smith M, et al. (2016) Get the GIST? An overview of gastrointestinal stromal tumours. Ir J Med Sci. 85:319–326CrossRef Watson GA, Kelly D, Melland-Smith M, et al. (2016) Get the GIST? An overview of gastrointestinal stromal tumours. Ir J Med Sci. 85:319–326CrossRef
14.
Zurück zum Zitat Kang HC, Menias CO, Gaballah AH, et al. (2013) Beyond the GIST: mesenchymal tumors of the stomach. RadioGraphics 33(6):1673–1690CrossRef Kang HC, Menias CO, Gaballah AH, et al. (2013) Beyond the GIST: mesenchymal tumors of the stomach. RadioGraphics 33(6):1673–1690CrossRef
15.
Zurück zum Zitat Demetri GD, Benjamin RS, Blanke CD, et al. (2007) NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)—update of the NCCN clinical practice guidelines. J Natl Compr Cancer Netw 5(Suppl 2):S1–S29 (quiz S30) Demetri GD, Benjamin RS, Blanke CD, et al. (2007) NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)—update of the NCCN clinical practice guidelines. J Natl Compr Cancer Netw 5(Suppl 2):S1–S29 (quiz S30)
16.
Zurück zum Zitat Huang RX, Xiang P, Huang C (2014) Gastrointestinal stromal tumors: current translational research and management modalities. Eur Rev Med Pharmacol Sci 18:3076–3085PubMed Huang RX, Xiang P, Huang C (2014) Gastrointestinal stromal tumors: current translational research and management modalities. Eur Rev Med Pharmacol Sci 18:3076–3085PubMed
18.
Zurück zum Zitat Miettinen M, Sobin LH, Lasota J (2005) Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29(1):52–68CrossRef Miettinen M, Sobin LH, Lasota J (2005) Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29(1):52–68CrossRef
19.
Zurück zum Zitat Linch M, Claus J, Benson C (2013) Update on imatinib for gastrointestinal stromal tumors: duration of treatment. Onco Targets Ther 6:1011–1023PubMedPubMedCentral Linch M, Claus J, Benson C (2013) Update on imatinib for gastrointestinal stromal tumors: duration of treatment. Onco Targets Ther 6:1011–1023PubMedPubMedCentral
20.
Zurück zum Zitat Therasse P, Arbuck SG, Eisenhauer EA (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216CrossRef Therasse P, Arbuck SG, Eisenhauer EA (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216CrossRef
21.
Zurück zum Zitat Shankar S, Dundamadappa SK, Karam AR, Stay RM, van Sonnenberg E (2009) Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy. Acta Radiol 50:837–844CrossRef Shankar S, Dundamadappa SK, Karam AR, Stay RM, van Sonnenberg E (2009) Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy. Acta Radiol 50:837–844CrossRef
22.
Zurück zum Zitat Chen MY, Bechtold RE, Savage PD (2002) Cystic changes in hepatic metastases from gastrointestinal stromal tumors (GISTs) treated with Gleevec (imatinib mesylate). Am J Roentgenol 179:1059–1062CrossRef Chen MY, Bechtold RE, Savage PD (2002) Cystic changes in hepatic metastases from gastrointestinal stromal tumors (GISTs) treated with Gleevec (imatinib mesylate). Am J Roentgenol 179:1059–1062CrossRef
23.
Zurück zum Zitat Connolly EM, Gaffney E, Reynolds JV (2003) Gastrointestinal stromal tumours. Br J Surg 90:1178–1186CrossRef Connolly EM, Gaffney E, Reynolds JV (2003) Gastrointestinal stromal tumours. Br J Surg 90:1178–1186CrossRef
24.
Zurück zum Zitat Choi H (2008) Response evaluation of gastrointestinal stromal tumors. Oncologist 13:4–7CrossRef Choi H (2008) Response evaluation of gastrointestinal stromal tumors. Oncologist 13:4–7CrossRef
25.
Zurück zum Zitat Benjamin RS, Choi H, Macapinlac HA, et al. (2007) We should desist using RECIST at least in GIST. J Clin Oncol 25:1760–1764CrossRef Benjamin RS, Choi H, Macapinlac HA, et al. (2007) We should desist using RECIST at least in GIST. J Clin Oncol 25:1760–1764CrossRef
26.
Zurück zum Zitat Chen YT, Sun HL, Luo JH, et al. (2014) Interventional digital subtraction angiography for small bowel gastrointestinal stromal tumors with bleeding. World J Gastroenterol 20(47):17955–17961CrossRef Chen YT, Sun HL, Luo JH, et al. (2014) Interventional digital subtraction angiography for small bowel gastrointestinal stromal tumors with bleeding. World J Gastroenterol 20(47):17955–17961CrossRef
27.
Zurück zum Zitat Alessiani M, Gianola M, Rossi S, et al. (2014) Peritonitis secondary to spontaneous perforation of a primary gastrointestinal stromal tumour of the small intestine. Int J Surg Case Rep 6:58–62CrossRef Alessiani M, Gianola M, Rossi S, et al. (2014) Peritonitis secondary to spontaneous perforation of a primary gastrointestinal stromal tumour of the small intestine. Int J Surg Case Rep 6:58–62CrossRef
Metadaten
Titel
Getting the GIST: a pictorial review of the various patterns of presentation of gastrointestinal stromal tumors on imaging
verfasst von
Dominic Scola
Lawrence Bahoura
Alexander Copelan
Ali Shirkhoda
Farnoosh Sokhandon
Publikationsdatum
10.01.2017
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 5/2017
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-1025-z

Weitere Artikel der Ausgabe 5/2017

Abdominal Radiology 5/2017 Zur Ausgabe

Classics in Abdominal Imaging

The “O” sign

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.